EA201001301A1 - APPLICATION OF 1-METHYL-2-FENYLTIOMETHYL-3-CARBETOXI-4-DIMETHYLAMINOMETHYL-5-OXI-6-BROMINDOL AND ITS SALTS FOR PREVENTION AND / OR TREATMENT OF INFECTIOUS DISEASES FOR HYDROGENES - Google Patents
APPLICATION OF 1-METHYL-2-FENYLTIOMETHYL-3-CARBETOXI-4-DIMETHYLAMINOMETHYL-5-OXI-6-BROMINDOL AND ITS SALTS FOR PREVENTION AND / OR TREATMENT OF INFECTIOUS DISEASES FOR HYDROGENESInfo
- Publication number
- EA201001301A1 EA201001301A1 EA201001301A EA201001301A EA201001301A1 EA 201001301 A1 EA201001301 A1 EA 201001301A1 EA 201001301 A EA201001301 A EA 201001301A EA 201001301 A EA201001301 A EA 201001301A EA 201001301 A1 EA201001301 A1 EA 201001301A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- dimethylaminomethyl
- salts
- methyl
- prevention
- treatment
- Prior art date
Links
Abstract
Изобретение относится к ветеринарии, конкретно к способу профилактики и/или лечения вирусных заболеваний животных путем применения 1-метил-2-фенилтиометил-3-карбэтокси-4-диметиламинометил-5-окси-6-броминдола и его солей, и может быть использовано преимущественно в промышленном животноводстве. Задача изобретения - обеспечение терапевтической эффективности профилактики и лечения инфекционных заболеваний животных вирусного генеза. Поставленная задача решается применением 1-метил-2-фенилтиометил-3-карбэтокси-4-диметиламинометил-5-окси-6-броминдола и его солей, обладающих противовирусной и иммуномодулирующей активностью, в ветеринарии, а также способом профилактики и/или лечения вирусных заболеваний животных, включающим парентеральное и/или пероральное введение животным препарата на основе 1-метил-2-фенилтиометил-3-карбэтокси-4-диметиламинометил-5-окси-6-броминдола или его солей в количестве 1,5-10 мг по действующему веществу на килограмм массы животного одним или двумя курсами продолжительностью от 10 до 20 суток.The invention relates to veterinary medicine, specifically to a method for the prevention and / or treatment of viral diseases of animals through the use of 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-hydroxy-6-bromoindole and its salts, and can be used mainly in industrial animal husbandry. The objective of the invention is the provision of therapeutic efficacy in the prevention and treatment of infectious diseases of animals of viral genesis. The problem is solved by using 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-hydroxy-6-bromindol and its salts, which have antiviral and immunomodulatory activity, in veterinary medicine, as well as a way to prevent and / or treat viral diseases animals, including parenteral and / or oral administration to animals of the drug based on 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-hydroxy-6-bromoindole or its salts in the amount of 1.5-10 mg by active ingredient per kilogram of animal mass one or two ursami lasting from 10 to 20 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA201001301A EA021130B1 (en) | 2010-07-19 | 2010-07-19 | Use of 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxy-6-bromeindole and salts thereof for prevention and/or treatment of infectious diseases in animals of virus genesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA201001301A EA021130B1 (en) | 2010-07-19 | 2010-07-19 | Use of 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxy-6-bromeindole and salts thereof for prevention and/or treatment of infectious diseases in animals of virus genesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201001301A1 true EA201001301A1 (en) | 2012-01-30 |
| EA021130B1 EA021130B1 (en) | 2015-04-30 |
Family
ID=45540644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201001301A EA021130B1 (en) | 2010-07-19 | 2010-07-19 | Use of 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxy-6-bromeindole and salts thereof for prevention and/or treatment of infectious diseases in animals of virus genesis |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA021130B1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2033156C1 (en) * | 1974-11-27 | 1995-04-20 | Центр по химии лекарственных средств | 6-bromo -5- hydroxy-4- dimethylaminomethyl -1- methyl -2-phenylthio- methylindole -3- carboxylic acid ethyl ester hydrochloride |
| RU2008004C1 (en) * | 1986-06-25 | 1994-02-28 | Центр по химии лекарственных средств - ВНИХФИ | Prophylactic and curative agent for treating flu virus b |
| RU2033157C1 (en) * | 1987-12-16 | 1995-04-20 | Центр по химии лекарственных средств | Drug possessing interferon-inducing and immunomodulating (immunostimulating) activity |
| RU2256451C1 (en) * | 2004-04-21 | 2005-07-20 | Закрытое акционерное общество "Мастерлек" | Medicinal agent for treatment of atypical pneumonia |
-
2010
- 2010-07-19 EA EA201001301A patent/EA021130B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA021130B1 (en) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012007410A (en) | Novel antiviral compounds. | |
| TW200600492A (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
| UA92746C2 (en) | Thiazole compounds and methods of use | |
| EA201171376A1 (en) | THYENO DERIVATIVES [2,3-B] PIRIDINE AS VIRUS REPLICATION INHIBITORS | |
| MY155649A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
| BR112014015482A2 (en) | phenyl carbamate compounds for use in the alleviation or treatment of pain and neuropathic pain | |
| EA201690069A1 (en) | THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE | |
| EA201490647A1 (en) | DERIVATIVES OF BENZOTHIAZOL-6-LUCUS ACID AND THEIR APPLICATION FOR THE TREATMENT OF HIV INFECTION | |
| EA201270144A1 (en) | COMBINED THERAPY FOR TREATMENT OF DIABETES | |
| EA201290078A1 (en) | HETEROCYCLIC COMPOUNDS TO INHIBIT PASK | |
| EA201391519A1 (en) | 2'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF THEIR USE FOR THE TREATMENT OF VIRAL DISEASES | |
| BR112013028132A2 (en) | dihydroxisoxazole compounds parasiticide | |
| BR112015010396A2 (en) | combination therapy | |
| EA200601281A1 (en) | AZABENZOFURANE-SUBSTITUTED THIOMOPHEIN; VIRUS REPLICATION INHIBITORS | |
| WO2007148919A8 (en) | Bacteriophage having killing activity specific to staphylococcus aureus | |
| EA201590697A1 (en) | DERIVATIVES OF KETAMINE | |
| EA201270615A1 (en) | ANTIGROUSE PREPARATION CONTAINING FUNGAL ORGANISM | |
| MX2012000275A (en) | Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement. | |
| RU2012124268A (en) | BENZIMIDAZOLE COMPOUNDS AND THEIR APPLICATIONS | |
| EP2572711A4 (en) | Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient | |
| WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
| MX2011011058A (en) | Selective ep4 receptor agonistic substance for treatment of cancer. | |
| MX2008011020A (en) | Imidazole compounds having pharmaceutical activity towards the sigma receptor. | |
| EA201390345A1 (en) | THERAPEUTIC HOSE MEDICINE | |
| EA201490417A1 (en) | NEW EASY DESTROYING PDE 4 INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |